Stress-Induced Ulcer Bleeding in Critically Ill Patients

Gastroenterology Clinics of North America

Volumn 38, Issue 2, 2009, Pages 245-265

  Ali, Tauseef ^a   Harty, Richard F ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Critically ill patients; Gastric mucosal damage; Gastrointestinal bleeding; Intensive care unit; Stress ulcers

Indexed keywords

ACETYLSALICYLIC ACID; ALUMINUM HYDROXIDE; AMOXICILLIN; ANTACID AGENT; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; CIMETIDINE; CLARITHROMYCIN; CYCLOOXYGENASE 2; DIAZEPAM; ENDOTHELIN 1; ESOMEPRAZOLE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; MAGNESIUM HYDROXIDE; MISOPROSTOL; NITRIC OXIDE; NIZATIDINE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PANTOPRAZOLE; PHENYTOIN; PROSTAGLANDIN E2; PROTON PUMP INHIBITOR; QUINIDINE; RANITIDINE; SUCRALFATE; THEOPHYLLINE; UNINDEXED DRUG;

ABDOMINAL DISCOMFORT; ALCOHOL ABUSE; ANGIOGRAPHY; ARTIFICIAL VENTILATION; BLOOD CLOTTING DISORDER; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE INFECTION; CONSTIPATION; CONTINUOUS INFUSION; CONTROLLED DRUG RELEASE; COST EFFECTIVENESS ANALYSIS; CRITICALLY ILL PATIENT; DEFENSE MECHANISM; DIARRHEA; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; DRUG WITHDRAWAL; ELECTIVE SURGERY; ENDOSCOPIC THERAPY; ENTERIC FEEDING; EPIDEMIOLOGICAL DATA; ESOPHAGOGASTRODUODENOSCOPY; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL TOXICITY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HYPOTENSION; INTESTINE BLOOD FLOW; INTESTINE INFECTION; INTESTINE ISCHEMIA; LIVER FAILURE; NEUROLOGIC DISEASE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PEPTIC ULCER BLEEDING; PNEUMONIA; RECEPTOR BLOCKING; REPERFUSION INJURY; RESPIRATORY FAILURE; REVIEW; RISK FACTOR; SEPSIS; STOMACH INTUBATION; STOMACH MUCOSA; STOMACH MUCOSA LESION; STOMACH PH; STRESS ULCER; THERMOCOAGULATION; THROMBOCYTOPENIA; UPPER GASTROINTESTINAL BLEEDING;

CRITICAL ILLNESS; GASTRIC MUCOSA; GASTROINTESTINAL HEMORRHAGE; HISTAMINE ANTAGONISTS; HUMANS; PROTON PUMP INHIBITORS; RISK FACTORS; STOMACH ULCER; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL;

EID: 65549138774     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2009.03.002     Document Type: Review

References (100)

1. Selye H. A syndrome produced by diverse nocuous agents. 1936. J Neuropsychiatry Clin Neurosci 10 2 (1998) 230-231
2. Curling T.B. On acute ulceration of the duodenum in cases of burn. Med Chir Trans (Lond) 25 (1842) 260-281
3. Lucas C.E., Sugawa C., Riddle J., et al. Natural history and surgical dilemma of "stress" gastric bleeding. Arch Surg 102 (1971) 266-273
4. Choung R.S., and Talley N.J. Epidemiology and clinical presentation of stress-related peptic damage and chronic peptic ulcer. Curr Mol Med 8 (2008) 253-257
5. ASHP therapeutic guidelines on stress ulcer prophylaxis. ASHP commission on therapeutics and approved by the ASHP board of directors on 1998. Am J Health Syst Pharm 56 (1999) 347-379
6. Peura D.A., and Johnson L.F. Cimetidine for prevention and treatment of gastroduodenal mucosal lesions in patients in an intensive care unit. Ann Intern Med 103 (1985) 173-177
7. Czaja A.J., McAlhany J.C., and Pruitt Jr. B.A. Acute gastroduodenal disease after thermal injury. An endoscopic evaluation of incidence and natural history. N Engl J Med 291 (1974) 925-929
8. Duerksen D.R. Stress-related mucosal disease in critically ill patients. Best Pract Res Clin Gastroenterol 17 (2003) 327-344
9. Shuman R.B., Schuster D.P., and Zuckerman G.R. Prophylactic therapy for stress ulcer bleeding: a reappraisal. Ann Intern Med 106 (1987) 562-567
10. Mutlu G.M., Mutlu E.A., and Factor P. GI complications in patients receiving mechanical ventilation. Chest 119 (2001) 1222-1241
11. Fennerty M.B. Pathophysiology of the upper gastrointestinal tract in the critically ill patient: rationale for the therapeutic benefits of acid suppression. Crit Care Med 30 (2002) S351-S355
12. Cook D.J., Reeve B.K., Guyatt G.H., et al. Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. JAMA 275 (1996) 308-314
13. Cook D.J., Fuller H.D., Guyatt G.H., et al. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med 330 (1994) 377-381
14. Cook D.J., Griffith L.E., Walter S.D., et al. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care 5 (2001) 368-375
15. Allen M.E., Kopp B.J., and Erstad B.L. Stress ulcer prophylaxis in the postoperative period. Am J Health Syst Pharm 61 (2004) 588-596
16. Laine L., Takeuchi K., and Tarnawski A. Gastric mucosal defense and cytoprotection: bench to bedside. Gastroenterology 135 (2008) 41-60
17. Hunter J. Digestion of the stomach after death. Philos Trans R Soc Lond B Biol Sci 62 (1772) 447-454
18. Virchow R. Historisches, kritisches und positives zur lehre der unterleibsaffektionen. Arch Anat Pathol 5 (1853) 281-375
19. Vane J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231 (1971) 232-235
20. Robert A., Nezamis J.E., Lancaster C., et al. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology 77 (1979) 433-443
21. Robert A., Nezamis J.E., Lancaster C., et al. Mild irritants prevent gastric necrosis through "adaptive cytoprotection" mediated by prostaglandins. Am J Phys 245 (1983) G113-G121
22. Dong M.H., and Kaunitz J.D. Gastroduodenal mucosal defense. Curr Opin Gastroenterol 22 (2006) 599-606
23. Ham M., and Kaunitz J.D. Gastroduodenal defense. Curr Opin Gastroenterol 23 (2007) 607-616
24. Kamada T., Sato N., Kawano S., et al. Gastric mucosal hemodynamics after thermal or head injury. A clinical application of reflectance spectrophotometry. Gastroenterology 83 (1982) 535-540
25. Leung F.W., Itoh M., Hirabayashi K., et al. Role of blood flow in gastric and duodenal mucosal injury in the rat. Gastroenterology 88 (1985) 281-289
26. Yasue N., and Guth P.H. Role of exogenous acid and retransfusion in hemorrhagic shock-induced gastric lesions in the rat. Gastroenterology 94 (1988) 1135-1143
27. Das D., Bandyopadhyay D., Bhattacharjee M., et al. Hydroxyl radical is the major causative factor in stress-induced gastric ulceration. Free Radic Biol Med 23 (1997) 8-18
28. Shian W.M., Sasaki I., Kamiyama Y., et al. The role of lipid peroxidation on gastric mucosal lesions induced by water-immersion-restraint stress in rats. Surg Today 30 (2000) 49-53
29. Sun Y., and Oberley L.W. Redox regulation of transcriptional activators. Free Radic Biol Med 21 (1996) 335-348
30. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 82 (2002) 47-95
31. Branger J., van den Blink B., Weijer S., et al. Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia. J Immunol 168 (2002) 4070-4077
32. Jia Y.T., Wei W., Ma B., et al. Activation of p38 MAPK by reactive oxygen species is essential in a rat model of stress-induced gastric mucosal injury. J Immunol 179 (2007) 7808-7819
33. Maricic N., Ehrlich K., Gretzer B., et al. Selective cyclo-oxygenase-2 inhibitors aggravate ischaemia-reperfusion injury in the rat stomach. Br J Pharmacol 128 (1999) 1659-1666
34. Schmedtje Jr. J.F., Ji Y.S., Liu W.L., et al. Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J Biol Chem 272 (1997) 601-608
35. Wada K., Kamisaki Y., Ohkura T., et al. Direct measurement of nitric oxide release in gastric mucosa during ischemia-reperfusion in rats. Am J Phys 274 (1998) G465-G471
36. Kobata A., Kotani T., Komatsu Y., et al. Dual action of nitric oxide in the pathogenesis of ischemia/reperfusion-induced mucosal injury in mouse stomach. Digestion 75 (2007) 188-197
37. Michida T., Kawano S., Masuda E., et al. Endothelin-1 in the gastric mucosa in stress ulcers of critically ill patients. Am J Gastroenterol 92 (1997) 1177-1181
38. Maynard N., Bihari D., Beale R., et al. Assessment of splanchnic oxygenation by gastric tonometry in patients with acute circulatory failure. JAMA 270 (1993) 1203-1210
39. Spirt M.J. Stress-related mucosal disease: risk factors and prophylactic therapy. Clin Ther 26 (2004) 197-213
40. Spirt M.J., and Stanley S. Update on stress ulcer prophylaxis in critically ill patients. Crit Care Nurse 26 (2006) 18-20 22-8
41. Ellison R.T., Perez-Perez G., Welsh C.H., et al. Risk factors for upper gastrointestinal bleeding in intensive care unit patients: role of Helicobacter pylori. Federal Hyperimmune Immunoglobulin Therapy Study Group. Crit Care Med 24 (1996) 1974-1981
42. Coursol C.J., and Sanzari S.E. Impact of stress ulcer prophylaxis algorithm study. Ann Pharmacother 39 (2005) 810-816
43. Erstad B.L., Camamo J.M., Miller M.J., et al. Impacting cost and appropriateness of stress ulcer prophylaxis at a university medical center. Crit Care Med 25 (1997) 1678-1684
44. Lam N.P., Le P.D., Crawford S.Y., et al. National survey of stress ulcer prophylaxis. Crit Care Med 27 (1999) 98-103
45. Barletta J.F., Erstad B.L., and Fortune J.B. Stress ulcer prophylaxis in trauma patients. Crit Care 6 (2002) 526-530
46. Daley R.J., Rebuck J.A., Welage L.S., et al. Prevention of stress ulceration: current trends in critical care. Crit Care Med 32 (2004) 2008-2013
47. Wade E.E., Rebuck J.A., Healey M.A., et al. H(2) antagonist-induced thrombocytopenia: is this a real phenomenon?. Intensive Care Med 28 (2002) 459-465
48. Epstein C.M. Histamine H2 antagonists and the nervous system. Am Fam Physician 32 (1985) 109-112
49. Humphries T.J., and Merritt G.J. Review article: drug interactions with agents used to treat acid-related diseases. Aliment Pharmacol Ther 3 (1999) 18-26
50. Siepler J.K., Trudeau W., and Petty D.E. Use of continuous infusion of histamine2-receptor antagonists in critically ill patients. DICP 23 (1989) S40-S43
51. Ostro M.J., Russell J.A., Soldin S.J., et al. Control of gastric pH with cimetidine: boluses versus primed infusions. Gastroenterology 89 (1985) 532-537
52. Somberg L., Morris Jr. J., Fantus R., et al. Intermittent intravenous pantoprazole and continuous cimetidine infusion: effect on gastric pH control in critically ill patients at risk of developing stress-related mucosal disease. J Trauma 64 (2008) 1202-1210
53. Pemberton L.B., Schaefer N., Goehring L., et al. Oral ranitidine as prophylaxis for gastric stress ulcers in intensive care unit patients: serum concentrations and cost comparisons. Crit Care Med 21 (1993) 339-342
54. Mathot R.A., and Geus W.P. Pharmacodynamic modeling of the acid inhibitory effect of ranitidine in patients in an intensive care unit during prolonged dosing: characterization of tolerance. Clin Pharmacol Ther 66 (1999) 140-151
55. Levy M.J., Seelig C.B., Robinson N.J., et al. Comparison of omeprazole and ranitidine for stress ulcer prophylaxis. Dig Dis Sci 42 (1997) 1255-1259
56. Phillips J.O., Metzler M.H., Palmieri M.T., et al. A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage. Crit Care Med 24 (1996) 1793-1800
57. Lasky M.R., Metzler M.H., and Phillips J.O. A prospective study of omeprazole suspension to prevent clinically significant gastrointestinal bleeding from stress ulcers in mechanically ventilated trauma patients. J Trauma 44 (1998) 527-533
58. Andersson T., Hassan-Alin M., Hasselgren G., et al. Drug interaction studies with esomeprazole, the (S)-isomer of omeprazole. Clin Pharm 40 (2001) 523-537
59. Stefanov C., Batashki I., Dimitrov D., et al. [Efficiency and safety of the intravenous application of esomeprazole (Nexium-Astra Zeneca) in high risk patients subjected to mechanical ventilation]. Khirurgiia 3 (2007) 25-28 [Bulgarian]
60. Tsai W.L., Poon S.K., Yu H.K., et al. Nasogastric lansoprazole is effective in suppressing gastric acid secretion in critically ill patients. Aliment Pharmacol Ther 14 (2000) 123-127
61. Olsen K.M., and Devlin J.W. Comparison of the enteral and intravenous lansoprazole pharmacodynamic responses in critically ill patients. Aliment Pharmacol Ther 3 (2008) 326-333
62. Huber R., Kohl B., Sachs G., et al. Review article: the continuing development of proton pump inhibitors with particular reference to pantoprazole. Aliment Pharmacol Ther 9 (1995) 363-378
63. Harty R.F., and Ancha H.B. Stress ulcer bleeding. Curr Treat Options Gastroenterol 9 (2006) 157-166
64. Conrad S.A., Gabrielli A., Margolis B., et al. Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients. Crit Care Med 33 (2005) 760-765
65. Klebl F.H., and Scholmerich J. Therapy insight: prophylaxis of stress-induced gastrointestinal bleeding in critically ill patients. Nat Clin Pract Gastroenterol Hepatol 4 (2007) 562-570
66. Zinner M.J., Rypins E.B., Martin L.R., et al. Misoprostol versus antacid titration for preventing stress ulcers in postoperative surgical ICU patients. Ann Surg 210 (1989) 590-595
67. Szabo S., and Hollander D. Pathways of gastrointestinal protection and repair: mechanisms of action of sucralfate. Am J Med 86 (1989) 23-31
68. Tryba M. Sucralfate versus antacids or H2-antagonists for stress ulcer prophylaxis: a meta-analysis on efficacy and pneumonia rate. Crit Care Med 19 (1991) 942-949
69. Hastings P.R., Skillman J.J., Bushnell L.S., et al. Antacid titration in the prevention of acute gastrointestinal bleeding: a controlled, randomized trial in 100 critically ill patients. N Engl J Med 298 (1978) 1041-1045
70. Maury E., Tankovic J., Ebel A., et al. An observational study of upper gastrointestinal bleeding in intensive care units: is Helicobacter pylori the culprit?. Crit Care Med 33 (2005) 1513-1518
71. Halm U., Halm F., Thein D., et al. Helicobacter pylori infection: a risk factor for upper gastrointestinal bleeding after cardiac surgery?. Crit Care Med 28 (2000) 110-113
72. van der Voort P.H., van der Hulst R.W., Zandstra D.F., et al. Prevalence of Helicobacter pylori infection in stress-induced gastric mucosal injury. Intensive Care Med 27 (2001) 68-73
73. Schilling D., Haisch G., Sloot N., et al. Low seroprevalence of Helicobacter pylori infection in patients with stress ulcer bleeding-a prospective evaluation of patients on a cardiosurgical intensive care unit. Intensive Care Med 26 (2000) 1832-1836
74. Yan R., Sun Y., and Sun R. [Early enteral feeding and supplement of glutamine prevent occurrence of stress ulcer following severe thermal injury]. Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi 11 (1995) 189-192 [Chinese]
75. MacLaren R., Jarvis C.L., and Fish D.N. Use of enteral nutrition for stress ulcer prophylaxis. Ann Pharmacother 35 (2001) 1614-1623
76. O'May G.A., Reynolds N., and Macfarlane G.T. Effect of pH on an in vitro model of gastric microbiota in enteral nutrition patients. Appl Environ Microbiol 71 (2005) 4777-4783
77. Thorens J., Froehlich F., Schwizer W., et al. Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study. Gut 39 (1996) 54-59
78. Zedtwitz-Liebenstein K., Wenisch C., Patruta S., et al. Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity. Crit Care Med 30 (2002) 1118-1122
79. Laheij R.J., Sturkenboom M.C., Hassing R.J., et al. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 292 (2004) 1955-1960
80. Cunningham R., Dale B., Undy B., et al. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect 54 (2003) 243-245
81. Tryba M. Risk of acute stress bleeding and nosocomial pneumonia in ventilated intensive care unit patients: sucralfate versus antacids. Am J Med 83 (1987) 117-124
82. Driks M.R., Craven D.E., Celli B.R., et al. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization. N Engl J Med 317 (1987) 1376-1382
83. Messori A., Trippoli S., Vaiani M., et al. Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials. BMJ 321 (2000) 1103-1106
84. Pepin J., Valiquette L., Alary M.E., et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 171 (2004) 466-472
85. Wilson K.H., Sheagren J.N., and Freter R. Population dynamics of ingested Clostridium difficile in the gastrointestinal tract of the Syrian hamster. J Infect Dis 151 (1985) 355-361
86. Dial S., Delaney J.A., Barkun A.N., et al. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 294 (2005) 2989-2995
87. Leonard J., Marshall J.K., and Moayyedi P. Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol 102 (2007) 2047-2056
88. Martinsen T.C., Bergh K., and Waldum H.L. Gastric juice: a barrier against infectious diseases. Basic Clin Pharmacol Toxicol 96 (2005) 94-102
89. Hurst A.F. The clinical importance of achlorhydria. BMJ 2 (1934) 665-669
90. Neal K.R., Briji S.O., Slack R.C., et al. Recent treatment with H2 antagonists and antibiotics and gastric surgery as risk factors for Salmonella infection. BMJ 308 (1994) 176
91. Neal K.R., Scott H.M., Slack R.C., et al. Omeprazole as a risk factor for campylobacter gastroenteritis: case-control study. BMJ 312 (1996) 414-415
92. Canani R.B., Cirillo P., Roggero P., et al. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics 117 (2006) e817-e820
93. Marik P.E., and Mohedin M. The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 272 (1994) 1354-1357
94. Khuroo M.S., Yattoo G.N., Javid G., et al. A comparison of omeprazole and placebo for bleeding peptic ulcer. N Engl J Med 336 (1997) 1054-1058
95. Beejay U., and Wolfe M.M. Acute gastrointestinal bleeding in the intensive care unit. The gastroenterologist's perspective. Gastroenterol Clin North Am 29 (2000) 309-336
96. Katschinski B., Logan R., Davies J., et al. Prognostic factors in upper gastrointestinal bleeding. Dig Dis Sci 39 (1994) 706-712
97. Kovacs T.O. Management of upper gastrointestinal bleeding. Curr Gastroenterol Rep 10 (2008) 535-542
98. Wischmeyer P.E., Riehm J., Singleton K.D., et al. Glutamine attenuates tumor necrosis factor-alpha release and enhances heat shock protein 72 in human peripheral blood mononuclear cells. Nutrition 19 (2003) 1-6
99. Akbulut K.G., Gonul B., Turkyilmaz A., et al. The role of epidermal growth factor formulation on stress ulcer healing of the gastric mucosa. Surg Today 32 (2002) 880-883
100. Woofter A., and Goodgame R. Grand rounds in gastroenterology from Baylor College of Medicine. Upper gastrointestinal bleeding in the ICU. MedGenMed 8 (2006) 43